Related references
Note: Only part of the references are listed.Meta-Analysis of Transradial Versus Transfemoral Access for Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease
Azka Latif et al.
AMERICAN JOURNAL OF CARDIOLOGY (2021)
A Review of Specific Biomarkers of Chronic Renal Injury and Their Potential Application in Nonclinical Safety Assessment Studies
Leslie A. Obert et al.
TOXICOLOGIC PATHOLOGY (2021)
Symmetric Dimethylarginine is Altered in Patients After Myocardial Infarction and Predicts Adverse Outcomes
Aleksandra Gasecka et al.
JOURNAL OF INFLAMMATION RESEARCH (2021)
Differential Effects of Ticagrelor With or Without Aspirin on Platelet Reactivity and Coagulation Activation: A Randomized Trial in Healthy Volunteers
Ludwig Traby et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Antithrombotic agents for primary and secondary prevention of cardiovascular events in patients with end-stage renal disease on chronic hemodialysis
Oliver Koenigsbruegge et al.
ATHEROSCLEROSIS (2020)
Ticagrelor and prasugrel are independent predictors of improved long-term survival in ACS patients
Gloria M. Gager et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2020)
Prolonged antithrombotic therapy in patients after acute coronary syndrome: A critical appraisal of current European Society of Cardiology guidelines
Jacek Kubica et al.
CARDIOLOGY JOURNAL (2020)
The 'Ten Commandments' for the 2020 ESC Guidelines for themanagement of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Jean-Philippe Collet et al.
EUROPEAN HEART JOURNAL (2020)
Medication adherence and its determinants in patients after myocardial infarction
Lukasz Pietrzykowski et al.
SCIENTIFIC REPORTS (2020)
Platelet reactivity patterns in patients treated with dual antiplatelet therapy
Max-Paul Winter et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2019)
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk
Philip Urban et al.
EUROPEAN HEART JOURNAL (2019)
Combinations of bleeding and ischemic risk and their association with clinical outcomes in acute coronary syndrome
Mohamed O. Mohamed et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
Impaired l-arginine metabolism marks endothelial dysfunction in CD73-deficient mice
P. Mierzejewska et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2019)
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention A Consensus Document From the Academic Research Consortium for High Bleeding Risk
Philip Urban et al.
CIRCULATION (2019)
Incidence, predictors, and prognosis of premature discontinuation or switch of prasugrel or ticagrelor: the ATLANTIS - SWITCH study
Max-Paul Winter et al.
SCIENTIFIC REPORTS (2019)
Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups
Georg Gelbenegger et al.
BMC MEDICINE (2019)
Stratified Approaches to Antiplatelet Therapies Based on Platelet Reactivity Testing
Matgorzata Ostrowska et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2019)
Chronic kidney disease and bleeding risk in patients at high cardiovascular risk: a cohort study
G. Ocak et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams: Focus on antiplatelet therapies. Updated experts' standpoint
Jacek Kubica et al.
CARDIOLOGY JOURNAL (2018)
Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation An ARISTOTLE Substudy
John D. Horowitz et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease
Insa E. Emrich et al.
CLINICAL RESEARCH IN CARDIOLOGY (2018)
Inter-patient variability of platelet reactivity in patients treated with prasugrel and ticagrelor
Jolanta M. Siller-Matula et al.
PLATELETS (2016)
Serum Concentrations of Symmetric Dimethylarginine and Creatinine in Dogs with Naturally Occurring Chronic Kidney Disease
J. A. Hall et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2016)
Glucocorticoid treatment inhibits intracerebral hemorrhage-induced inflammation by targeting the microRNA-155/SOCS-1 signaling pathway
Hong-Fei Xu et al.
MOLECULAR MEDICINE REPORTS (2016)
Distribution of clinical events across platelet aggregation values in all-comers treated with prasugrel and ticagrelor
Jolanta M. Siller-Matula et al.
VASCULAR PHARMACOLOGY (2016)
Impact of chronic kidney disease on long-term ischemic and bleeding outcomes in medically managed patients with acute coronary syndromes: Insights from the TRILOGY ACS Trial
Chiara Melloni et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2016)
The net clinical benefit of personalized antiplatelet therapy in patients undergoing percutaneous coronary intervention
Jolanta M. Siller-Matula et al.
CLINICAL SCIENCE (2015)
Major bleeding risk prediction using Chronic Kidney Disease Epidemiology Collaboration and Modification of Diet in Renal Disease equations in acute coronary syndrome
Pedro J. Flores-Blanco et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2015)
Interplay between Genetic and Clinical Variables Affecting Platelet Reactivity and Cardiac Adverse Events in Patients Undergoing Percutaneous Coronary Intervention
Jolanta M. Siller-Matula et al.
PLOS ONE (2014)
Abnormal High-Density Lipoprotein Induces Endothelial Dysfunction via Activation of Toll-like Receptor-2
Thimoteus Speer et al.
IMMUNITY (2013)
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction Comorbidities Drive Myocardial Dysfunction and Remodeling Through Coronary Microvascular Endothelial Inflammation
Walter J. Paulus et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Impact of renal function on clopidogrel-induced antiplatelet effects in coronary artery disease patients without diabetes mellitus
Antonio Tello-Montoliu et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2013)
Chronic kidney disease is associated with increased platelet activation and poor response to antiplatelet therapy
Thomas Gremmel et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS-PCI study
J. M. Siller-Matula et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Symmetric Dimethylarginine as a Proinflammatory Agent in Chronic Kidney Disease
Eva Schepers et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Long-Term Impact of Chronic Kidney Disease in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention The HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial
Adam J. Saltzman et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2011)
Symmetrical Dimethylarginine Outperforms CKD-EPI and MDRD-Derived eGFR for the Assessment of Renal Function in Patients with Adult Congenital Heart Disease
Oktay Tutarel et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2011)
SDMA is an early marker of change in GFR after living-related kidney donation
Jan T. Kielstein et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke
Friedrich Schulze et al.
ATHEROSCLEROSIS (2010)
Impact of Chronic Kidney Disease on Platelet Function Profiles in Diabetes Mellitus Patients With Coronary Artery Disease Taking Dual Antiplatelet Therapy
Dominick J. Angiolillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
Latika Sibal et al.
CURRENT CARDIOLOGY REVIEWS (2010)
Impact of Chronic Kidney Disease on Early (30-Day) and Late (1-Year) Outcomes of Patients With Acute Coronary Syndromes Treated With Alternative Antithrombotic Treatment Strategies An ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Substudy
Roxana Mehran et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2009)
Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes
Eva Schepers et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure
Wai Hong Wilson Tang et al.
EUROPEAN HEART JOURNAL (2008)
PAI-1 as a target in kidney disease
Yufeng Huang et al.
CURRENT DRUG TARGETS (2007)
Symmetric dimethylarginine (SDMA) as endogenous marker of renal function - a meta-analysis
Jan T. Kielstein et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Symmetrical dimethylarginine:: A new combined parameter for renal function and extent of coronary artery disease
Stefanie M. Bode-Boeger et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Platelet dysfunction in renal failure
P Boccardo et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2004)
Review on uremic toxins:: Classification, concentration, and interindividual variability
R Vanholder et al.
KIDNEY INTERNATIONAL (2003)
Share Paper
